ONCAlert | 2017 NANETS Symposium

A Study of Chemotherapy With Durvalumab and Tremelimumab in NSCLC

Rosalyn Juergens, MD, PhD
Published Online:2:35 PM, Wed February 8, 2017

Rosalyn Juergens, MD, PhD, assistant professor, Department of Oncology, Division of Medical Oncology, McMaster University, discusses a clinical trial investigating chemotherapy with durvalumab and tremelimumab in patients with non-small cell lung cancer (NSCLC).
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.